NANETS Treatment Guidelines
Top Cited Papers
- 1 August 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Pancreas
- Vol. 39 (6) , 735-752
- https://doi.org/10.1097/mpa.0b013e3181ebb168
Abstract
Well-differentiated neuroendocrine tumors (NETs) of the stomach and pancreas represent 2 major subtypes of gastrointestinal NETs. Historically, there has been little consensus on the classification and management of patients with these tumor subtypes. We provide an overview of well-differentiated NETs of the stomach and pancreas and describe consensus guidelines for the treatment of patients with these malignancies.Keywords
This publication has 171 references indexed in Scilit:
- Gastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine TumorsGastroenterology, 2008
- Inherited pancreatic endocrine tumor syndromes: Advances in molecular pathogenesis, diagnosis, management, and controversiesCancer, 2008
- Prospective Study of Surgery for Primary Hyperparathyroidism (HPT) in Multiple Endocrine Neoplasia-Type 1 and Zollinger-Ellison SyndromeAnnals of Surgery, 2008
- Cytotoxic treatment including embolization/chemoembolization for neuroendocrine tumoursBest Practice & Research Clinical Endocrinology & Metabolism, 2007
- Surgery on neuroendocrine tumoursBest Practice & Research Clinical Endocrinology & Metabolism, 2007
- TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading systemVirchows Archiv, 2006
- Surgery Increases Survival in Patients With GastrinomaAnnals of Surgery, 2006
- Gastric carcinoid tumors in multiple endocrine neoplasia-1 patients with Zollinger-Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgical treatmentSurgery, 2004
- A 5‐decade analysis of 13,715 carcinoid tumorsCancer, 2003
- Cushing's Syndrome in Patients with the Zollinger–Ellison SyndromeNew England Journal of Medicine, 1986